Pathophysiology | OA Readiness Practice | Verified Q&A |
Pass Guaranteed - A+ Graded
Q1: A 58-year-old male presents with crushing substernal chest pain radiating to the left
arm, diaphoresis, and nausea. Troponin I is elevated at 8.5 ng/mL (normal <0.04). ECG
shows ST-segment elevation in leads V1-V4. Which pathophysiological mechanism is
primarily responsible for his myocardial injury?
A. Coronary artery vasospasm without thrombosis
B. Atherosclerotic plaque rupture with thrombus formation and complete coronary
occlusion
C. Gradual coronary stenosis from stable angina without acute thrombosis
D. Myocardial oxygen supply-demand mismatch without coronary obstruction
Correct Answer: B
Rationale: ST-elevation myocardial infarction (STEMI) results from atherosclerotic
plaque rupture exposing prothrombotic material (lipid core, tissue factor), triggering
thrombus formation and complete coronary artery occlusion. This produces transmural
infarction with ST elevation. A describes Prinzmetal's angina (vasospastic angina),
which causes transient ST elevation without significant troponin elevation; C describes
stable angina or chronic coronary syndrome without acute infarction; D describes type 2
MI (supply-demand mismatch from hypotension, anemia, or tachycardia) without plaque
rupture. The clinical presentation (crushing pain, radiation, diaphoresis, nausea, marked
troponin elevation, ST elevation in anterior leads) is pathognomonic for acute plaque
rupture with thrombotic occlusion (type 1 MI).
,Q2: A 45-year-old female with type 1 diabetes presents with polyuria, polydipsia, fruity
breath odor, Kussmaul respirations, and abdominal pain. Laboratory studies reveal:
glucose 485 mg/dL, pH 7.25, HCO3- 12 mEq/L, anion gap 22, ketones positive in serum
and urine. Which metabolic derangement distinguishes this condition from
hyperosmolar hyperglycemic state (HHS)?
A. Degree of hyperglycemia
B. Presence of metabolic acidosis with elevated anion gap
C. Serum osmolality
D. Level of consciousness
Correct Answer: B
Rationale: Diabetic ketoacidosis (DKA) is fundamentally distinguished from HHS by the
presence of metabolic acidosis with elevated anion gap due to ketone body
accumulation (β-hydroxybutyrate, acetoacetate). Both conditions feature severe
hyperglycemia, but DKA: pH <7.3, HCO3- <18, anion gap >10, positive ketones; HHS: pH
>7.3, HCO3- >18, minimal ketones, normal anion gap. A is incorrect—HHS typically has
higher glucose (>600 mg/dL) than DKA; C—both have elevated osmolality, though HHS
more extreme (>320 mOsm/kg); D—altered mental status occurs in both, more common
in HHS. The acid-base disorder with ketosis is the pathophysiological hallmark
differentiating DKA.
Q3: A 62-year-old male with chronic alcohol use presents with severe epigastric pain
radiating to the back, nausea, and vomiting. Serum lipase is elevated at 1,200 U/L. CT
abdomen shows diffuse pancreatic edema with peripancreatic fluid collections. Which
cellular mechanism initiates this pathophysiological process?
A. Autoimmune destruction of pancreatic acinar cells
B. Premature activation of trypsinogen to trypsin within acinar cells, leading to
autodigestion
C. Bacterial infection of the pancreatic parenchyma
,D. Isolated sphincter of Oddi dysfunction without parenchymal involvement
Correct Answer: B
Rationale: Acute pancreatitis initiates with intracellular activation of digestive
zymogens, primarily trypsinogen → trypsin conversion within acinar cells. Trypsin then
activates other enzymes (phospholipase A2, elastase, carboxypeptidase), causing
autodigestion of pancreatic parenchyma, acinar cell necrosis, and inflammation.
Alcohol and gallstones (most common causes) trigger this pathway through calcium
overload, mitochondrial dysfunction, and impaired autophagy. A describes autoimmune
pancreatitis (IgG4-related disease), a chronic condition with different pathophysiology;
C—infection is a complication, not initiator; D—sphincter dysfunction may contribute but
doesn't explain parenchymal autodigestion. The "trypsin-centered" theory remains
central to understanding acute pancreatitis pathogenesis.
Q4: A 28-year-old female presents with fatigue, weight gain, cold intolerance,
constipation, and dry skin. Laboratory studies show TSH 12.5 mIU/L (normal 0.4-4.0),
free T4 0.6 ng/dL (normal 0.8-1.8). Which pathophysiological mechanism explains her
primary laboratory abnormality?
A. Thyroid-stimulating immunoglobulins stimulating TSH receptors
B. Autoimmune destruction of thyroid follicular cells with lymphocytic infiltration
C. Excessive iodine intake blocking thyroid hormone synthesis
D. TSH-secreting pituitary adenoma
Correct Answer: B
Rationale: Primary hypothyroidism with elevated TSH and low free T4 indicates thyroid
gland failure. Hashimoto's thyroiditis (chronic autoimmune thyroiditis) involves CD4+
T-cell mediated autoimmune destruction of thyroid follicular cells, lymphocytic
infiltration, and eventual fibrosis. Anti-TPO and anti-thyroglobulin antibodies are typically
present. A describes Graves' disease (hyperthyroidism); C describes the Wolff-Chaikoff
, effect (usually transient); D describes secondary hyperthyroidism from TSHoma (rare,
would show elevated T4). The clinical picture (hypothyroid symptoms) with biochemical
pattern (high TSH, low T4) confirms autoimmune thyroid gland destruction.
Q5: A 70-year-old male with hypertension and diabetes presents with progressive
dyspnea on exertion, orthopnea, and lower extremity edema. Echocardiogram shows
left ventricular ejection fraction of 35% with dilated left ventricle. Which neurohormonal
activation is most responsible for the pathological remodeling in this condition?
A. Excessive nitric oxide production causing vasodilation
B. Activation of renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous
system
C. Suppression of natriuretic peptides
D. Inhibition of endothelin-1 release
Correct Answer: B
Rationale: HFrEF (heart failure with reduced ejection fraction) pathophysiology centers
on neurohormonal activation: decreased cardiac output triggers baroreceptor-mediated
RAAS activation (angiotensin II → vasoconstriction, aldosterone → sodium/water
retention, fibrosis) and sympathetic nervous system activation (norepinephrine →
tachycardia, vasoconstriction, direct myocardial toxicity). These initially compensate but
cause maladaptive remodeling—myocyte hypertrophy, apoptosis, fibrosis, and
progressive pump failure. A is incorrect—NO is beneficial and reduced in HF;
C—natriuretic peptides are elevated (compensatory) but insufficient to counteract RAAS;
D—endothelin-1 is increased in HF, contributing to vasoconstriction. RAAS and
sympathetic activation are therapeutic targets (ACE inhibitors, ARBs, beta-blockers,
MRAs).
Q6: A 55-year-old female presents with morning stiffness lasting >60 minutes,
symmetric swelling of MCP and PIP joints, and subcutaneous nodules over extensor